Daratumumab with PD-1 Inhibitor Study Discontinued for Multiple Myeloma
Clinical Trials and Compassionate Use in Multiple Myeloma
Introducing HealthTree for Multiple Myeloma Patients with Rafael Fonseca, MD, Mayo Clinic Scottsdale
Dr. Rafael Fonseca joins Myeloma Crowd Radio to share a new tool for myeloma patients called HealthTree.
Donate Vitamin Bottles to TerraCycle, Raise Money for the Myeloma Crowd
Understanding the Mutations that Cause Multiple Myeloma May Help Drive Personalized Treatment
How Fast Your Multiple Myeloma Responds To Treatment May be Linked to Survival
Clinical Trials: What are Bispecific Antibodies?
New York Round Table - May 5, 2018
Blood Biopsies vs Bone Marrow Biopsies – The Good News For The Week …
Antibody-Drug Conjugates and Multiple Myeloma
MCRT Review: St Louis, Missouri – March 10, 2018
Only Your Genes Will Tell
Patient Power: How Can Myeloma Patients Combat Neuropathy?
First Risk-Adapted Therapy Trial for Newly Diagnosed Patients (the MASTER trial) with Luciano Costa, MD, PhD, UAB
Dr. Costa shares a key study for newly diagnosed multiple myeloma patients
Charlotte Round Table - April 14, 2018
Researchers Suggest Increased Screening of MGUS Patients to Prevent Multiple Myeloma
Lenalidomide Every Other Day for Myeloma Patients with Kidney Concerns?
Changing Careers in Midst of Myeloma…
Neutropenia in Multiple Myeloma and What You Need to Know
Baltimore Round Table - March 28, 2018
How Do I Exercise with Myeloma If I Am Elderly or Frail?
New Drug Targeting WT1 Found to Be Effective as Post-Transplant Myeloma Therapy for High-Risk Patients
Clinical Trial: Four Drug Induction Before Transplant Using Monoclonal Antibody for Newly Diagnosed Myeloma
Patient Power: Is Sugar Part of a Myeloma-Friendly Diet?
